Stock & Company Details
Gain Therapeutics Inc $GANX
Price:
N/A
N/A
44M
$81M
52 Week High:
N/A
10 Day Average Volume:
N/A
-2.97
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Technology
GANX technical indicators
Latest Gain Therapeutics Inc (GANX) indicator readings as of 2026-08-28.
GANX's 14-day RSI is 42.3, in neutral territory. At $1.77 it is trading 19.3% below its 200-day moving average of $2.19, and below its 50-day average of $1.85. Price sits in the middle of its Bollinger Bands ($1.65 to $2.21). ADX reads 16.9, indicating a range-bound market rather than a trend.
Select a strategy to see its performance
Backtested on this stock over recent history.
| Strategy | Trend | Return | Win rate |
|---|---|---|---|
| MACD Momentum Momentum Buy when MACD turns positive (crosses above zero) and RSI confirms momentum above 50; sell when MACD falls back below zero. | – | – | |
| RSI Reversal Mean reversion Buy when RSI falls below 30 (oversold), sell when it climbs above 70 (overbought). | – | – | |
| Volatility Breakout Volatility Buy when price closes above the upper Bollinger Band, sell on reversion to the 20-day average. | – | – | |
| Strong-Trend Pullback Trend + timing In strongly trending stocks (ADX above 25), buy short-term dips (Stochastic below 30) and sell into overbought (above 80). | – | – |
Overview
Gain Therapeutics Inc is a biotechnology company developing novel small molecule therapeutics to treat diseases across, several therapeutics areas, including, lysosomal storage disorders, central nervous system disorders, metabolic disorders and oncology. The company has filed four patent applications for novel small molecule drug candidates that are Structurally Targeted Allosteric Regulators (STARs). The company derives revenues from collaboration and licensing agreements.
Finance Bot
Ask your questions
Start by typing a question below.
